Peripheral plasma determinations of prostaglandin E in asthmatics

Joseph Allegra, Joseph Trautlein, Laurence Demers, John Field, Marilyn Gillin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Prostaglandins, unsaturated fatty acid derivatives with diversified pharmacologic activity, have recently been implicated in the pathophysiology of reversible airway disease. This study attempted to elucidate baseline prostaglandin E (PGE) plasma levels in asthmatics and the change in these levels after stimulation by a β-adrenergic agent. Fourteen stable, ambulant patients with reversible airway disease and 28 nonatopic control subjects were studied. All had baseline PGE levels performed. The asthmatics were asked to abstain from all medication for 10 hr prior to evaluation. After baseline evaluation consisting of plasma PGE determination, pulmonary function test, blood pressure, and heart rate, 375 μg of aerosolized terbutaline sulfate was administered to 8 of the asthmatics plus 4 of the nonatopic control subjects; the above measurements were repeated at 15, 30, and 60 min after administration. There was a statistically significant difference in baseline plasma PGE levels between the asthmatics (PGE = 432 ± 81) and the nonatopic control subjects (PGE = 89 ± 9) (p < 0.002). Following terbutaline administration, there was no significant change observed in PGE levels in asthmatic or in control individuals (asthmatics: 0 min, 570, 15 min, 513, 30 min, 514, 60 min, 608; normal subjects: 0 min, 138, 15 min, 137, 30 min, 143, 60 min, 214). In summary, we observed a significant difference in baseline PGE levels between asthmatic and nonatopic control persons. No change, however, was noted in PGE levels after β-adrenergic receptor stimulation. This observation is consistent with the current hypothesis that β-adrenergic agents act independently of prostaglandins to increase adenyl cyclase and modify bronchiole smooth muscle tone.

Original languageEnglish (US)
Pages (from-to)546-550
Number of pages5
JournalThe Journal of Allergy and Clinical Immunology
Volume58
Issue number5
DOIs
StatePublished - Jan 1 1976

Fingerprint

Prostaglandins E
Terbutaline
Adrenergic Agents
Prostaglandins
Bronchioles
Respiratory Function Tests
Unsaturated Fatty Acids
Adenylyl Cyclases
Adrenergic Receptors
Smooth Muscle
Heart Rate
Blood Pressure

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Allegra, Joseph ; Trautlein, Joseph ; Demers, Laurence ; Field, John ; Gillin, Marilyn. / Peripheral plasma determinations of prostaglandin E in asthmatics. In: The Journal of Allergy and Clinical Immunology. 1976 ; Vol. 58, No. 5. pp. 546-550.
@article{97f58f6744184e48a6587be813ce14ce,
title = "Peripheral plasma determinations of prostaglandin E in asthmatics",
abstract = "Prostaglandins, unsaturated fatty acid derivatives with diversified pharmacologic activity, have recently been implicated in the pathophysiology of reversible airway disease. This study attempted to elucidate baseline prostaglandin E (PGE) plasma levels in asthmatics and the change in these levels after stimulation by a β-adrenergic agent. Fourteen stable, ambulant patients with reversible airway disease and 28 nonatopic control subjects were studied. All had baseline PGE levels performed. The asthmatics were asked to abstain from all medication for 10 hr prior to evaluation. After baseline evaluation consisting of plasma PGE determination, pulmonary function test, blood pressure, and heart rate, 375 μg of aerosolized terbutaline sulfate was administered to 8 of the asthmatics plus 4 of the nonatopic control subjects; the above measurements were repeated at 15, 30, and 60 min after administration. There was a statistically significant difference in baseline plasma PGE levels between the asthmatics (PGE = 432 ± 81) and the nonatopic control subjects (PGE = 89 ± 9) (p < 0.002). Following terbutaline administration, there was no significant change observed in PGE levels in asthmatic or in control individuals (asthmatics: 0 min, 570, 15 min, 513, 30 min, 514, 60 min, 608; normal subjects: 0 min, 138, 15 min, 137, 30 min, 143, 60 min, 214). In summary, we observed a significant difference in baseline PGE levels between asthmatic and nonatopic control persons. No change, however, was noted in PGE levels after β-adrenergic receptor stimulation. This observation is consistent with the current hypothesis that β-adrenergic agents act independently of prostaglandins to increase adenyl cyclase and modify bronchiole smooth muscle tone.",
author = "Joseph Allegra and Joseph Trautlein and Laurence Demers and John Field and Marilyn Gillin",
year = "1976",
month = "1",
day = "1",
doi = "10.1016/0091-6749(76)90200-1",
language = "English (US)",
volume = "58",
pages = "546--550",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "5",

}

Peripheral plasma determinations of prostaglandin E in asthmatics. / Allegra, Joseph; Trautlein, Joseph; Demers, Laurence; Field, John; Gillin, Marilyn.

In: The Journal of Allergy and Clinical Immunology, Vol. 58, No. 5, 01.01.1976, p. 546-550.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Peripheral plasma determinations of prostaglandin E in asthmatics

AU - Allegra, Joseph

AU - Trautlein, Joseph

AU - Demers, Laurence

AU - Field, John

AU - Gillin, Marilyn

PY - 1976/1/1

Y1 - 1976/1/1

N2 - Prostaglandins, unsaturated fatty acid derivatives with diversified pharmacologic activity, have recently been implicated in the pathophysiology of reversible airway disease. This study attempted to elucidate baseline prostaglandin E (PGE) plasma levels in asthmatics and the change in these levels after stimulation by a β-adrenergic agent. Fourteen stable, ambulant patients with reversible airway disease and 28 nonatopic control subjects were studied. All had baseline PGE levels performed. The asthmatics were asked to abstain from all medication for 10 hr prior to evaluation. After baseline evaluation consisting of plasma PGE determination, pulmonary function test, blood pressure, and heart rate, 375 μg of aerosolized terbutaline sulfate was administered to 8 of the asthmatics plus 4 of the nonatopic control subjects; the above measurements were repeated at 15, 30, and 60 min after administration. There was a statistically significant difference in baseline plasma PGE levels between the asthmatics (PGE = 432 ± 81) and the nonatopic control subjects (PGE = 89 ± 9) (p < 0.002). Following terbutaline administration, there was no significant change observed in PGE levels in asthmatic or in control individuals (asthmatics: 0 min, 570, 15 min, 513, 30 min, 514, 60 min, 608; normal subjects: 0 min, 138, 15 min, 137, 30 min, 143, 60 min, 214). In summary, we observed a significant difference in baseline PGE levels between asthmatic and nonatopic control persons. No change, however, was noted in PGE levels after β-adrenergic receptor stimulation. This observation is consistent with the current hypothesis that β-adrenergic agents act independently of prostaglandins to increase adenyl cyclase and modify bronchiole smooth muscle tone.

AB - Prostaglandins, unsaturated fatty acid derivatives with diversified pharmacologic activity, have recently been implicated in the pathophysiology of reversible airway disease. This study attempted to elucidate baseline prostaglandin E (PGE) plasma levels in asthmatics and the change in these levels after stimulation by a β-adrenergic agent. Fourteen stable, ambulant patients with reversible airway disease and 28 nonatopic control subjects were studied. All had baseline PGE levels performed. The asthmatics were asked to abstain from all medication for 10 hr prior to evaluation. After baseline evaluation consisting of plasma PGE determination, pulmonary function test, blood pressure, and heart rate, 375 μg of aerosolized terbutaline sulfate was administered to 8 of the asthmatics plus 4 of the nonatopic control subjects; the above measurements were repeated at 15, 30, and 60 min after administration. There was a statistically significant difference in baseline plasma PGE levels between the asthmatics (PGE = 432 ± 81) and the nonatopic control subjects (PGE = 89 ± 9) (p < 0.002). Following terbutaline administration, there was no significant change observed in PGE levels in asthmatic or in control individuals (asthmatics: 0 min, 570, 15 min, 513, 30 min, 514, 60 min, 608; normal subjects: 0 min, 138, 15 min, 137, 30 min, 143, 60 min, 214). In summary, we observed a significant difference in baseline PGE levels between asthmatic and nonatopic control persons. No change, however, was noted in PGE levels after β-adrenergic receptor stimulation. This observation is consistent with the current hypothesis that β-adrenergic agents act independently of prostaglandins to increase adenyl cyclase and modify bronchiole smooth muscle tone.

UR - http://www.scopus.com/inward/record.url?scp=0017091732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017091732&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(76)90200-1

DO - 10.1016/0091-6749(76)90200-1

M3 - Article

C2 - 977861

AN - SCOPUS:0017091732

VL - 58

SP - 546

EP - 550

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5

ER -